Video & Transcript : 'pharmaceutical expansion' :
Page 62 of 386
LA
Louisiana 2026 Regular Session
Commerce May 20th, 2026
Commerce, Consumer Protection, and International Affairs
Transcript Highlights:
- review board process, which is the ethical review of a trial, so that we are fast because in the pharmaceutical
Summary:
The committee took up several House measures. HCR 66, as amended, asked Louisiana Economic Development and the Governor’s Office of Rural Development to study rural parish assets, infrastructure, workforce, and development opportunities, and it was moved forward without objection. HB 387, a clarification to allow the fire marshal’s office to review architectural and engineering plans equally, also passed favorably without objection. HB 1223, which would have LED promote Louisiana’s clinical trial capacity and adjust internal review board processes, was amended and moved favorably. HB 950, aimed at helping older adults recognize and avoid fraud through materials and resources from the Office of Elderly Affairs, was reported favorably. HB 975, a routine measure to recreate the Public Service Commission, was also reported favorably. HB 1186, which would create a more uniform statewide building code and licensing system for inspectors, was amended and moved favorably. HB 1222, described as a Grocery Initiative Act to let LED identify ways to address food deserts and food insecurity, was introduced near the end of the meeting.
The most extensive debate centered on HB 617, a consumer transparency bill requiring mandatory fees to be included in upfront pricing. The author said the bill was intended to curb hidden fees and help consumers compare prices, with examples such as hotel resort fees and automatic restaurant service charges. Supporters argued it would improve transparency, while opponents from grocery, restaurant, hotel, housing, retail, and business groups said the bill was too broad, vague about terms like “total price,” unclear on enforcement and penalties, and could create compliance burdens and litigation risk, especially for small businesses. Housing advocates opposed the bill’s housing carve-out, arguing it could weaken renters’ ability to bring unfair-practice claims. Senator Morris moved to defer HB 617, and the committee agreed without objection.
The committee also heard lengthy testimony on HB 797, which would create a Bayou Gold certification for certain transactional gold vendors that meet state-defined standards such as segregation, insurance, and nearby storage. The sponsor said the goal was to give consumers confidence and encourage vendors to keep gold closer to Louisiana, while critics argued the program would amount to a state endorsement of private companies, create misleading consumer impressions, and expose the state to confusion or liability. The bill drew opposition from the Sound Money Defense League and others, but the committee ultimately reported HB 797 favorably, with the understanding it still had to go to Finance. HB 1228, a hearing-aid cleanup bill updating definitions, contracts, testing periods, and licensing rules, was also moved favorably without objection.
LA
Louisiana 2026 Regular Session
Commerce May 20th, 2026
Commerce, Consumer Protection, and International Affairs
Transcript Highlights:
- review board process, which is the ethical review of a trial, so that we are fast because in the pharmaceutical
Summary:
The Senate Commerce Committee met on April 20, approved the prior meeting minutes, and then heard a series of bills and resolutions. It first advanced H. CR 66, which directs Louisiana Economic Development, working with the Governor’s Office of Rural Development, to study rural parish economic assets, infrastructure, workforce, and development opportunities. The committee also moved HB 387, a clarification allowing the fire marshal to review architectural and engineering plans equally, and HB 1223, which seeks to promote clinical trials in Louisiana by having LED market the state’s research capacity and by adjusting internal review board procedures. HB 1228, a cleanup bill for hearing aid dealers that updates definitions, contracts, testing periods, licensing, and related requirements, was also reported favorably, as was HB 950, which would create an elderly consumer perception program through the Office of Elderly Affairs to help seniors recognize scams and fraud.
The committee spent the most time on HB 617, a broad “hidden fees” consumer transparency bill. The author and supporters said it would require mandatory fees to be included in upfront pricing so consumers can make informed choices, while opponents from grocery, restaurant, hotel, housing, retail, and business groups argued the bill was vague, overly broad, and likely to create compliance burdens and litigation risk. Housing advocates objected to the bill’s housing exemption, warning it could weaken renters’ ability to bring claims over undisclosed fees. After extensive debate over variable pricing, sales taxes, enforcement, and the scope of the bill, Senator Morris moved to defer HB 617, and the committee agreed without objection.
The committee also heard HB 797, which would create a “Bayou Gold” certification program for certain gold vendors and transactional gold products. The sponsor said the program would encourage vendors to keep gold insured, segregated, and closer to Louisiana consumers, with the Treasury administering the certification through participant fees. Several senators and an outside witness raised concerns that the state seal could be mistaken for an endorsement, could create liability or consumer confusion, and would favor a narrow set of vendors. Despite opposition, the committee reported HB 797 favorably, with members noting it still had to go to Finance. Later, the committee advanced HB 1186, which would create a more uniform statewide building code and licensing system for inspectors, add disciplinary authority, and impose a small permit fee to support the program, and HB 1222, which would let LED develop a grocery initiative to address food deserts and food insecurity. The meeting concluded with the committee hearing HB 1256 on abandoned digital assets, which would require dormant digital assets to be held in original form for three years so owners can reclaim them.
WA
Washington 2025-2026 Regular Session
House Environment & Energy May 18th, 2026
Transcript Highlights:
- This includes pesticides, paints, pharmaceuticals, cleaners, and other common chemicals.
Summary:
The committee held an interim work session focused first on carbon capture, utilization, and sequestration (CCUS), then on hazardous waste and extended producer responsibility (EPR). On the CCUS topic, industry and nonprofit presenters described point-source capture, direct air capture, mineralization, and geologic sequestration, emphasizing Washington’s basalt formations and state trust lands as strong candidates for storage. They argued that CCUS can help hard-to-abate industrial sectors, support jobs and investment, and provide a pathway for compliance, while also noting the need for clearer permitting, subsurface rights, pipeline authority, and storage infrastructure. Ecology and Commerce staff explained current state policy touchpoints, including Cap-and-Invest offsets and exemptions for permanently stored CO2, the public comment process underway to define “thousand-year” permanence, and how CCUS might fit within the Clean Energy Transformation Act without counting emitting generation as non-emitting. Some presenters supported more state action and primacy over federal permitting, while others warned about costs, energy use, uncertain capture performance, and the need to ensure real net greenhouse gas reductions and long-term liability protections.
Members asked about public meetings, whether mineralized carbon would qualify as exempt under the Climate Commitment Act, the timeline for Ecology guidance, aquifer and water-quality concerns, energy intensity of capture systems, and liability if storage later proves problematic. Responses said Ecology’s guidance process is already underway, public meetings will be virtual, mineralized carbon would likely qualify if it meets the permanence standard, and EPA rules require storage in deep saline formations below drinking water aquifers. Industry speakers said capture energy use varies by source and concentration, and one presenter noted that some states use trust funds funded by injectors to address long-term liability.
The second half of the session shifted to hazardous waste and EPR. Ecology staff reviewed existing product stewardship programs for electronics, paint, batteries, and mercury lights, and described moderate risk waste and household hazardous waste management in Washington. They highlighted that E-Cycle and PaintCare are producer-funded, that the battery stewardship program will begin in 2027, and that the mercury lamp program is in transition after its prior stewardship organization exited, prompting enforcement notices and a pending replacement plan. Ecology recommended best practices for future EPR programs, including clear producer and product definitions, full producer funding, convenience standards, annual reporting, and strong agency enforcement and plan approval authority. Local government speakers from King County and Douglas County described rising collection costs, equity and access barriers, rural travel distances, and the need for stable funding and flexible local implementation. King County said it collected over 3 million pounds of hazardous products in 2025 and supports EPR as a way to shift costs from ratepayers to producers, while Douglas County emphasized that rural residents will participate when services are accessible and that future systems should account for geography and local infrastructure.
OK
Oklahoma 2026 Regular Session
House of Representatives Second Regular Session of the 60th Legislature Day 41 Apr 15th, 2026
Oklahoma House Floor Meeting
Transcript Highlights:
- And so they have skewed the costs in the pharmaceutical market so badly that we are now running pharmacists
Bills:
HR1051 , HR1048 , SB2074 , SJR39 , SJR47 , SB1983 , SB444 , SB1503 , SB1561 , SB592 , SB1501 , SB1946 , SB1567 , SB1833 , SB2026 , SB904 , SB2178 , SB1651 , SB1558 , SB1565 , SB1553 , SB1257 , SB65 , SB1749 , SB1242 , SB1642 , SB640 , SB667 , SB1436 , SB1484 , SB1562 , SB1794 , SB1644 , SB1533 , SB933 , SB1555
Summary:
The House opened with prayer, the Pledge of Allegiance, and a series of special presentations and introductions celebrating Oklahoma State University, the Cowgirl Wrestling Club, the OSU livestock judging team, military children, poster contest winners, and several visiting groups and honorees. The chamber also recognized the Doctor of the Day, Dr. Kurt Emerson, and the Nurse of the Day, Beverly Felton. Much of the floor time was devoted to OSU Day remarks, including a citation honoring the university and comments from Speaker Hilbert, Coach Eric Morris, and President Jim Hess.
The House then took up Senate Bill 2074, a pharmacy benefit manager measure intended to regulate PBMs and support pharmacists. An amendment by Representative Jenkins to remove a section of the bill was tabled, and members questioned the bill extensively about reimbursement rates, consumer costs, employer options, transparency, and the impact on independent pharmacies. After debate, the bill advanced and passed the House by a vote of 87-7.
Members also considered Senate Joint Resolution 39, which would place a constitutional amendment on the ballot to cap property tax growth. The measure, as amended, would set a 1.75% annual cap on homestead property tax growth and a 4% cap on other properties, with a stair-step senior freeze. The resolution drew debate over effects on local government revenue, schools, roads, jails, and inflation, but supporters argued it would provide strong taxpayer protections. The House passed the resolution 85-9 and then took the additional vote required to refer the constitutional amendment to a special election.
LA
Transcript Highlights:
- Pharmaceutical Care Management Association made it clear that states can regulate how pharmacies are
Committee:
House Insurance
AZ
Arizona 2026 Regular Session
02/18/2026 - Senate Health and Human Services
Senate Health and Human Services COR
Transcript Highlights:
- cannibalizing dollars for the state that are spent, you know, paying PBMs and insurance companies and pharmaceutical
Committee:
Senate Senate Health and Human Services COR
Summary:
The committee approved the minutes and then took up a large agenda of health-related bills. SB 1214, the Arizona Stem Cell Therapy Act, drew extensive testimony from supporters who said it would create guardrails for regenerative medicine, protect patients, and encourage biotech investment, while opponents argued it was tied to abortion politics and imposed harsh penalties. The bill passed on a 4-3 vote. SB 1194, which would prohibit health professionals and institutions from denying care based on vaccination status, also passed 4-3 after testimony from supporters framing it as an access-to-care and religious-freedom measure and opponents warning it would interfere with private practice policies and parental choice. SB 1814, creating a study committee on substance use disorder treatment standards and oversight, passed unanimously 7-0. SB 1602, increasing stipends for kinship foster parents, passed as amended 7-0, and SB 1603, expanding child-only cash assistance eligibility, also passed as amended 7-0.
The committee then considered several bills focused on gender-related care and public funding. SB 1177, which bars public monies from funding gender transition procedures and makes intentional violations a felony, passed 4-3 amid testimony that it protects taxpayers and counterarguments that it is discriminatory and unsupported by evidence. SB 1014, requiring insurance coverage for detransition procedures when transition care is covered and directing data reporting on transition and detransition, passed 4-3 after supporters said it would help detransitioners and collect needed data, while opponents argued it would chill providers and target transgender patients. SB 1094, creating civil liability for physicians who perform irreversible gender reassignment surgery on minors, was heard with testimony from supporters citing malpractice concerns and detransitioner harms and from opponents saying it would create a hostile environment for providers and treat trans patients differently; the transcript cuts off before the vote is shown. SB 1752, which classifies commercial harvesting or sale of mescaline as a felony while preserving bona fide religious use defenses, passed unanimously 7-0.
Later, SB 1628, requiring insurers to report claims-denial and prior-authorization data and DIFI to publish standardized reports, passed unanimously 7-0 after supporters emphasized transparency and opponents called it redundant to federal reporting. SB 1629, requiring AHCCCS managed care organizations to give advance notice and network-adequacy documentation before terminating high-volume providers without cause, also passed 7-0; supporters said it would prevent patients from losing access to behavioral health care, while health plans and Access said existing oversight already covers much of this and warned the bill could slow necessary network changes. Throughout the meeting, the committee repeatedly adopted motions for due-pass recommendations and, where applicable, amendments, with several bills passing on party-line or near-party-line votes.
NM
New Mexico 2026 Regular Session
Senate - Tax, Business and Transportation Feb 7th, 2026
Transcript Highlights:
- It is frightening to see our medicinal pharmaceutical plants that have sustained us for centuries unable
Summary:
The committee first took up the proposed 2026 tax package, Senate Bill 151, and adopted a committee substitute after discussion of the package’s funding capacity and included measures. The substitute bundled five bills: a physician tax credit, a quantum facility infrastructure tax credit, a construction materials gross receipts deduction for affordable multifamily housing, a local journalist employment tax credit, and a health equipment gross receipts deduction. Members discussed amendments that raised the physician credit from $4,000 to $10,000, narrowed the housing deduction to project-based certification, and reduced the journalist credit threshold from four stories to three. Concerns were raised about the fiscal impact on municipalities, especially Albuquerque, and about the funding mechanism, but the committee voted 6-4 to give the substitute a do pass recommendation. Senator Sanchez explained his vote, saying he wished more could have been included in the package.
The committee then heard Senate Bill 18, the Clear Horizons Act, which would codify statewide greenhouse gas reduction targets and direct the Environment Department and Environmental Improvement Board to develop plans and rules for emissions reductions. The sponsors said the bill builds on the governor’s 2019 executive order, includes a 10,000-metric-ton threshold for covered emitters, allows certified offsets, and is intended to protect public health, reduce climate-related costs, and provide regulatory certainty. Supporters argued the bill would help communities facing wildfire, drought, health harms, and rising insurance and utility costs, and that it would encourage clean-energy investment and long-term economic stability.
Opposition testimony came from mining, oil and gas, rural electric cooperatives, construction, agriculture, auto dealers, chambers of commerce, banks, water recycling companies, and realtors. They argued the bill functions like a carbon tax or broad regulatory mandate, would raise energy and compliance costs, could reduce investment and jobs, and would disproportionately affect rural, tribal, agricultural, and low-income communities. Several witnesses warned of higher electricity and fuel bills, revenue losses for local governments, and uncertainty from delegating major policy decisions to rulemaking. Supporters included public health advocates, educators, local officials, clean-energy businesses, tribal and environmental advocates, and residents affected by wildfire and drought, who said the bill is necessary to address climate harms and protect public health and the economy. No final committee vote on SB 18 was reached in the portion provided.
WA
Transcript Highlights:
- unanswered questions that those records could help answer, such as toxicology reports that include pharmaceuticals
Committee:
House Transportation
Keywords:
vehicle loads, public highways, transportation, road safety, infrastructure, HB2139, snowmobile registration, snowmobile fee, vehicle license fee, registration fee, Department of Licensing, RCW, vehicle registration, winter recreation, off-road vehicle, moped, motorcycle, trailer, recreational vehicle, vintage snowmobile
NM
New Mexico 2025 Regular Session
IC - Legislative Health and Human Services Sep 11th, 2025
Legislative Health & Human Services Committee
Transcript Highlights:
- You've got supplies and pharmaceuticals coming in after that. You've got some non-capital costs.
CA
California 2025-2026 Regular Session
Assembly Budget Subcommittee No. 1 on Health May 20th, 2025
Transcript Highlights:
- I am the Chief of the Pharmaceutical Policy and Programs Branch at HCAI.
US
US Federal 2025-2026 Regular Session
Joint hearings with the House Select Committee on the Strategic Competition to examine financial aggression, focusing on how the Chinese Communist Party exploits American retirees and undermines national security. Apr 9th, 2025 at 01:30 pm
Aging (Special) Committee
Transcript Highlights:
- It was a pharmaceutical company.
Committee:
Senate Aging (Special) Committee
Keywords:
Chinese Communist Party, retirement security, investment risks, SEC enforcement, Bipartisan action
Summary:
The meeting primarily addressed concerns regarding the impact of the Chinese Communist Party (CCP) on American investments and the financial security of retirees. The chair discussed legislation aimed at ensuring the protection of American investors against the risks posed by Chinese companies. There was a consensus among the members regarding the necessity to enforce existing policies that require compliance from foreign companies wishing to trade on American exchanges. The discussion included testimony from various stakeholders highlighting the urgent need to limit exposure to the CCP in retirement portfolios. Additionally, there were calls for increased accountability of regulatory bodies such as the SEC to better shield American investors from potential loss.
FL
Florida 2025 Regular Session
March 31, 2025 - 04:00 PM
Transcript Highlights:
- Pharmaceutical costs up 33 percent.
Summary:
The committee took up a large health and human services agenda and first approved HB 711, the Spectrum Alert bill, which would create a statewide alert system for missing autistic children and require FDLE to coordinate training with state and local agencies. The measure drew a supportive waiver from the Florida Smart Justice Alliance and passed unanimously, 24-0, reported favorably.
Members then considered CS for HB 229 on health facilities, which modernizes the Health Facilities Authority Act to allow additional nonprofit health system structures to use tax-exempt financing. Two amendments were adopted: one requiring advance notice, public hearings, and stakeholder notifications before a nonprofit hospital closure, and another removing a property tax exemption for a nonprofit hospital that closes and fails to maintain emergency services for 120 days, applied retroactively to January 1, 2025. The Florida Hospital Association opposed the amendments, citing workforce and nonprofit-status concerns, but the bill as amended passed 24-0. The committee also approved CS for HB 1405 on juvenile justice status offenders, expanding early truancy intervention, parent involvement, and shelter placement review timelines; it passed 24-0. CS for HB 27, joining the Social Work Licensure Interstate Compact, and its linked public records bill CS for HB 29 both passed unanimously after supportive testimony from several advocacy and business groups.
The committee then debated HB 111 on out-of-network referrals and HB 1083 on patient access to records. HB 111 would require referring practitioners to inform patients in writing when a referral is out of network and to apply out-of-network payments to deductibles; it drew opposition from medical groups over administrative burden and patient-care concerns, but passed 17-8. HB 1083 would shorten the time for producing medical records to 14 working days and standardize access rules, with amendments clarifying portal access and delaying the effective date to January 1, 2026; despite opposition from some health information and provider groups over HIPAA and access concerns, it passed 19-7 as amended.
Later, the committee approved HB 883, allowing autonomous practice for psychiatric nurse practitioners with the required credentials, after strong support from nurse practitioner groups and opposition from psychiatric and medical associations; it passed 23-3. HB 1297, which aligns Florida’s electronic prescribing exceptions with federal law and removes several state exemptions, passed 19-7 despite opposition from hospice, emergency physician, rheumatology, and medical groups concerned about paper prescriptions in emergencies and hard-to-find medications. HB 1353 on home health care services and CS for HB 989 on foster home licensure transfers both passed unanimously after supportive amendments. The committee also heard HB 1505 on parental rights, which would require written parental consent for many health care services, surveys, and biofeedback devices for minors and expand parental access to records; the bill drew extensive support testimony but also questions and concerns about confidentiality, abuse reporting, and existing exceptions, and the transcript ended before a final vote on that bill.
FL
Transcript Highlights:
- said kratom is not a boogeyman and, for many people, represents a healthier alternative to big pharmaceutical
Committee:
Senate Commerce and Tourism
Summary:
The committee first took up a committee substitute for SB 752, which would require newspapers and television stations to remove online reports later found to be false or defamatory in certain circumstances, and would change when the statute of limitations begins to run. The sponsor said the bill was intended to address lasting harm from false accusations that remain searchable online. Several speakers opposed the measure, arguing it would chill reporting, punish accurate historical coverage, and create vague legal risks for the press. After debate, the committee reported the bill favorably.
The committee then approved CS/SB 846, a bill aimed at preventing immigration service fraud by non-attorneys and misuse of the term "notario." Supporters, including an immigration attorney, said the bill would protect vulnerable immigrants from bad advice and fake legal services. The committee also approved CS/SB 800, which updates battery labeling and recycling requirements to reduce fires caused by discarded batteries; waste and recycling representatives supported it, while a battery industry group warned the bill could effectively ban battery-embedded products. CS/SB 578, dealing with wine container rules and allowing recyclable inserts and boxes up to 5.16 gallons, was also reported favorably.
The committee next approved CS/SB 1734, the Florida Kratom Consumer Protection Act, which sets product standards, labeling rules, age limits, testing, and enforcement provisions. Supporters said it reflects current science and consumer safety needs, while opponents warned it could burden small businesses and overregulate the market. SB 918, which would loosen state child labor restrictions for certain minors and align Florida law more closely with federal standards, drew extensive opposition from advocates, students, and labor groups who said it would increase exploitation and harm education; several senators also raised concerns, but the bill was still reported favorably. The committee also reported favorably SB 854 on unlicensed contractors and deposit fraud, and confirmed several appointments to state boards and commissions. A separate bill on online encryption and child safety, SB 868, was taken up with an amendment and public testimony, but the transcript cuts off before final action on that item.
US
US Federal 2025-2026 Regular Session
Hearings to examine the nominations of Christopher Landau, of Maryland, to be Deputy Secretary, Michael Rigas, of Virginia, to be Deputy Secretary for Management and Resources, and Matthew Whitaker, of Iowa, to be United States Permanent Representati Mar 4th, 2025 at 09:00 am
Foreign Relations Committee
Transcript Highlights:
- Shutting down USAID has meant that we have cut 100,000 American jobs. logistics management, pharmaceutical
Committee:
Senate Foreign Relations Committee
NH
New Hampshire 2025 Regular Session
House Criminal Justice and Public Safety (01/23/2025)
Criminal Justice and Public Safety
Transcript Highlights:
- Harm reduction services, things like expansion of the availability of naloxone, so more people who overdose
- They would have difficulty surviving without a number of pharmaceutical medications that are required
- They would have difficulty surviving without a number of pharmaceutical medications that are required
- They would have difficulty surviving without a number of pharmaceutical medications that are required
- They would have difficulty surviving without a number of pharmaceutical medications that are required
Committee:
House Criminal Justice and Public Safety
WY
Wyoming 2026 Regular Session
House Floor Session-Day 19, March 4, 2026-AM
Wyoming House Floor Meeting
Transcript Highlights:
- Um, and it's not that I distrust pharmacists, but I have very little trust in our pharmaceutical companies
- Um, and it's not that I distrust pharmacists, but I have very little trust in our pharmaceutical companies
- We just don't trust pharmaceuticals.
NH
New Hampshire 2025 Regular Session
House Finance Division III (03/12/2025)
Transcript Highlights:
- We would all assume a medical benefit comes from all pharmaceuticals, but you’re making a distinction
- We would all assume a medical benefit comes from all pharmaceuticals, but you’re making a distinction
Summary:
The working session focused on the New Hampshire Prescription Drug Affordability Board’s budget request and its recent work. Early discussion centered on a technical question about a statutory dedicated fund for donations: members asked why the budget did not show a line item for accepting donations, and DHHS CFO Nathan White explained that the statute already authorizes the fund, but because no revenue has been received yet, it does not appear in the budget. He said any future donations would go through the normal process under RSA 14:30-a, with fiscal committee and Governor and Council approval and a memo to the Department of Revenue Administration. The chair clarified that the account was not a prerequisite to soliciting donations, and White said the fund would supplement, not replace, General Fund support.
Kirk Williamson, the board’s executive director, then presented the board’s mission and budget. He said the governor’s budget provides about $256,500 in the first year and slightly more in the second, all General Funds, and that the board had distributed a technical amendment to continue the executive director position. He described the board’s role as analyzing prescription drug costs, identifying savings opportunities, monitoring market trends, promoting transparency, and making recommendations to the legislature and public payers. He also emphasized that the board operates publicly, with live-streamed meetings and a stakeholder advisory council that includes unions, state agencies, Medicaid, corrections, higher education, and other stakeholders.
A major topic was the board’s estimate of $6 million in potential savings, based on Medicare’s newly negotiated prices for 10 drugs. Williamson explained that the board used those federal negotiated prices as a benchmark to estimate what New Hampshire public payers might be missing by not having similar leverage, and said the board is trying to build evidence for future recommendations rather than directly setting prices. Members asked how those potential savings could become actual savings, and Williamson said the board is sharing findings through its advisory council and feedback loops, though it has not yet sent a formal recommendation letter to specific purchasers. He also discussed the difference between pharmacy-benefit spending, which relies heavily on PBM-negotiated rebates, and medical-benefit spending, which is administered differently and is being added to the board’s next report.
Williamson highlighted other work, including a model on Humira and a pending legislative effort to improve biosimilar competition, plus a proposed state-backed pharmacy savings card that would be no cost to the state and could save users about $240 per prescription based on Connecticut’s experience. No votes were taken during the session.
KY
Kentucky 2025 Regular Session
House Standing Committee on Health Services (2-20-25)
Transcript Highlights:
- So we've heard these testimonies about access to fluoride, but it's not a pharmaceutical-grade product
- access to fluoride but it's<01:17:56.400><c> not</c><01:17:56.520><c> a</c><01:17:56.679><c> pharmaceutical
Summary:
The committee first took up House Bill 392, sponsored by Representative Proctor, which would help the Department for Behavioral Health, Developmental and Intellectual Disabilities pay for emergency medical and psychiatric services provided to patients outside state facilities when those facilities cannot meet their needs. Proctor described it as a continuing improvement bill to address payment issues for services delivered at community-based facilities. The bill received no substantive opposition in the meeting and passed the committee with favorable expression by a vote of 15 yes, 0 no, and 1 pass.
The committee then considered House Bill 580, presented by Representative Kim Moser and Elena Sweezy, which tightens oversight of peer support specialists. The bill was described as building on House Bill 505 from the prior year by reinstating supervision requirements, adding parameters around group sizes, creating a pathway for temporary peer support specialists to become fully registered after nine months, and addressing Medicaid reimbursement and accountability concerns. Members asked about reimbursement; the sponsor said Medicaid was okay with the bill and that commercial insurance coverage would be up to insurers. Representative Fleming emphasized the need for stronger financial oversight of the peer support code. The committee adopted a substitute and title amendment, then passed the bill with favorable expression.
House Bill 688 was then heard, with Representative Bratcher explaining that it addresses two issues: preventing fraud in nurse licensure by giving the Kentucky Board of Nursing more discretion to review out-of-state credentials, and expanding school authority to administer certain emergency medications. He said the bill changes the board’s authority from “shall” to “may” so it can verify transcripts, curricula, accreditation, and exam passage. During discussion, Representative Sharp explained his yes vote by noting the bill also adds rescue medications such as glucagon and Solu-Cortef and allows prescribed emergency medications for known conditions in schools. The committee passed the bill with favorable expression.
Finally, the committee heard House Bill 16, which would leave decisions about adding fluoride to drinking water to local governing bodies rather than maintaining a state mandate. Supporters, including Representative David Hale, Dr. Jack Call, and Cindy Batson, argued that fluoridation should be a local choice and raised concerns about cost, potential health risks, and the precautionary principle. Opponents, including Dr. Steve Robertson of the Kentucky Dental Association, defended fluoridation as beneficial for preventing tooth decay and warned that local removal decisions could increase Medicaid costs and may not reflect the broader public interest. The transcript provided does not show a final committee vote on House Bill 16 in the excerpt.
NH
New Hampshire 2025 Regular Session
House Health, Human Services and Elderly Affairs (03/12/2025)
Health, Human Services & Elderly Affairs
Transcript Highlights:
- vaccine efficacy, many of those studies are done by other states, academic organizations, and the pharmaceutical
- that comes out might be studied in a placebo-controlled clinical trial, but there are multiple pharmaceutical
- that comes out might be studied in a placebo-controlled clinical trial, but there are multiple pharmaceutical
- clinical trial but there<04:05:35.439><c> are</c><04:05:35.920><c> multiple</c><04:05:36.920><c> pharmaceutical
- </c> there are multiple pharmaceutical there are multiple pharmaceutical companies<04:05:38.080><c> that
US